FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises
Nearly 11 years ago, scientists programmed a pair of molecular scissors to make precise cuts in DNA. That first test tube experiment of CRISPR gene …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
